Literature DB >> 27079527

Challenges of Active Surveillance Protocols for Low-Risk Papillary Thyroid Microcarcinoma in the United States.

Grace C Haser1, R Michael Tuttle2, Mark L Urken3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27079527     DOI: 10.1089/thy.2016.0109

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  6 in total

Review 1.  Active Surveillance of Papillary Thyroid Microcarcinoma: Where Do We Stand?

Authors:  Min Ji Jeon; Won Gu Kim; Ki-Wook Chung; Jung Hwan Baek; Won Bae Kim; Young Kee Shong
Journal:  Eur Thyroid J       Date:  2019-09-25

2.  Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.

Authors:  Nazanene H Esfandiari; David T Hughes; David Reyes-Gastelum; Kevin C Ward; Ann S Hamilton; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

Review 3.  Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea.

Authors:  Tae Yong Kim; Young Kee Shong
Journal:  Endocrinol Metab (Seoul)       Date:  2017-12

4.  Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression.

Authors:  Viviana Anelli; Jacques A Villefranc; Sagar Chhangawala; Raul Martinez-McFaline; Eleonora Riva; Anvy Nguyen; Akanksha Verma; Rohan Bareja; Zhengming Chen; Theresa Scognamiglio; Olivier Elemento; Yariv Houvras
Journal:  Elife       Date:  2017-03-28       Impact factor: 8.140

5.  Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma.

Authors:  Min Ji Jeon; Yea Eun Kang; Jae Hoon Moon; Dong Jun Lim; Chang Yoon Lee; Yong Sang Lee; Sun Wook Kim; Min-Hee Kim; Bo Hyun Kim; Ho-Cheol Kang; Minho Shong; Sun Wook Cho; Won Bae Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-03-23

6.  Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.

Authors:  Catherine B Jensen; Megan C Saucke; Susan C Pitt
Journal:  BMC Cancer       Date:  2021-04-28       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.